This document is a guideline for the management of COVID-19 in children and adolescents.
This document presents revised comprehensive guidelines for the management of COVID-19 in children and adolescents (below 18 years) issued by the Government of India's Ministry of Health and Family Welfare. The guidelines were updated in January 2022 to address the surge in cases attributed to the Omicron variant of concern. Key updates include changes to the title to explicitly include adolescents, revised diagnostic criteria for Multisystem Inflammatory Syndrome in Children (MIS-C), and specific recommendations regarding the use of corticosteroids and anticoagulants.
No, the use of antivirals or monoclonal antibodies is not recommended for children less than 18 years of age, irrespective of the severity of infection.
If steroids are used, they should be tapered over 10-14 days, subject to clinical improvement.